SOL-GEL TECHNOLOGIES LTD (SLGL) Stock Price, Quote, News and Overview
NASDAQ:SLGL - Nasdaq - IL0011417206 - Common Stock - Currency: USD
SLGL Quote, Performance and Key Statistics
SOL-GEL TECHNOLOGIES LTD
NASDAQ:SLGL (2/5/2025, 8:27:23 PM)
After market: 0.723 -0.04 (-4.99%)0.761
+0.05 (+7.17%)
The current stock price of SLGL is 0.761 USD. In the past month the price decreased by -23.88%. In the past year, price decreased by -41.46%.
SLGL Latest News, Press Releases and Analysis
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement ...
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates...
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Sol-Gel reports Second Quarter 2024 Financial Results and provides Corporate Updates...
SLGL Stock Earnings: Sol-Gel Technologies Beats EPS, Beats Revenue for Q2 2024
SLGL stock results show that Sol-Gel Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SLGL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 82.81 | 799.50B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.06 | 380.66B | ||
| JNJ | JOHNSON & JOHNSON | 15.48 | 372.43B | ||
| MRK | MERCK & CO. INC. | 11.74 | 226.83B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.62 | 219.98B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.86 | 219.54B | ||
| PFE | PFIZER INC | 8.5 | 149.84B | ||
| SNY | SANOFI-ADR | 13.51 | 134.13B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 51.03 | 121.10B | ||
| ZTS | ZOETIS INC | 30.5 | 79.26B | ||
| GSK | GSK PLC-SPON ADR | 9.11 | 76.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.09 | 42.39B |
Related stock screener links
About SLGL
Company Profile
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Company Info
SOL-GEL TECHNOLOGIES LTD
Golda Meir 7
Ness Ziona 7403648 IL
CEO: Alon Seri-Levy
Employees: 36
Company Website: http://www.sol-gel.com
Investor Relations: http://ir.sol-gel.com
Phone: 97289313433
SLGL FAQ
What is the stock price of SLGL?
The current stock price of SLGL is 0.761 USD.
What is the symbol for SOL-GEL TECHNOLOGIES LTD stock?
The exchange symbol of SOL-GEL TECHNOLOGIES LTD is SLGL and it is listed on the Nasdaq exchange.
On which exchange is SLGL stock listed?
SLGL stock is listed on the Nasdaq exchange.
Is SLGL a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SLGL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SLGL.
Does SLGL stock pay dividends?
SLGL does not pay a dividend.
What is the Price/Earnings (PE) ratio of SLGL?
SLGL does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
What is the Short Interest ratio of SLGL stock?
The outstanding short interest for SLGL is 2.16% of its float.
SLGL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to SLGL. When comparing the yearly performance of all stocks, SLGL is a bad performer in the overall market: 68.86% of all stocks are doing better.
SLGL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SLGL. The financial health of SLGL is average, but there are quite some concerns on its profitability.
SLGL Financial Highlights
Over the last trailing twelve months SLGL reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS decreased by 68.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.51% | ||
| ROE | -42.73% | ||
| Debt/Equity | 0 |
SLGL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to SLGL. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 71.72% and a revenue growth 870.39% for SLGL